Loading...

OncoCyte Corp ($OCX)

Stock Image

OCX Overview

OncoCyte Corporation engages in the development and commercialization of proprietary laboratory-developed tests for the detection of cancer.The company offers DetermaRx, a molecular tests for early stage adenocarcinoma of the lung; and DetermaIO, a novel gene expression-based tests. It also develops DetermaDx, a non-invasive blood-based tests used to detect lung cancer.OncoCyte Corporation has a strategic collaboration with Guardian Research Network, Inc. to create a solution for pharma clients from patient recruitment to regulatory approvals.The company was founded in 2009 and is headquartered in Irvine, California. (From: StockAnalysis.com)

MORE ABOUT OncoCyte Corp

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.